Sign In

Rationale for FGFR Inhibition and Value of Erdafitinib in Metastatic Urothelial Carcinoma

Event Date : Nov 11, 2022 12:00 PM - 01:00 PM

Details

Chat Box

  • { (x.title == null ? '' : x.title) + ' ' + (x.first_name == null ? '' : x.first_name) + ' ' + (x.middle_name == null ? '' : x.middle_name) + ' ' + (x.last_name == null ? '' : x.last_name) }
    { diffForHumans(x.created_at) }

    { x.comment }
    Replies

    • { (y.title == null ? '' : y.title) + ' ' + (y.first_name == null ? '' : y.first_name) + ' ' + (y.middle_name == null ? '' : y.middle_name) + ' ' + (y.last_name == null ? '' : y.last_name) } { diffForHumans(y.created_at) }

      { y.comment }